Efficacy and safety of levocetirizine in seasonal allergic rhinitis
1. 文件大小不能超过300M, 允许上传文档或压缩包等
2. 请确保上传文献的真实性、完整性,不得对原文做任何修改
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接: https://pubmed.ncbi.nlm.nih.gov/11859651
其他信息:
PMID: 11859651
作者: F Leynadier; K Mees; C Arendt; M E Pinelli; F Leynadier; ...
摘要: Objective: Pharmacodynamic studies have demonstrated that levocetirizine is the active enantiomer of cetirizine. This first therapeutic trial of levocetirizine aimed at determining the dosage with the best benefit/risk ratio in patients with seasonal allergic rhinitis (SAR).

